A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Inclusion Criteria: * Patient is aged 18 years or over on date of consent * Written informed consent (from patient or a legally authorized representative) to participate in study, documenting willingness and ability to comply with all study procedures and study visits (unless an exemption for emergency cases has been IRB / EC approved) * Patient's need for open surgical repair of the thoracic aorta using a Gelweave graft or a Thoraflex Hybrid device (AnteFlo or Plexus) in line with the applicable IFU * Anticipated need to use Rapidlink for the repair or replacement of the LSA, LCCA and/or IA during the open surgical repair * Patient has an 8-15 mm inner diameter (target SAV) * The diameters of the patient's target supra-aortic vessel(s), fall within the ranges specified in the IFU Exclusion Criteria: * Patient does not have a clear landing zone equal to the implantable stent length which is free from stenosis, calcification or thrombus. * Patient does not have a sealing zone free from tortuosity. * Patient has significant angulation (\>79° with an internal radius of less than 6mm) for the full implantable stent length * Patient cannot receive anticoagulation / antiplatelet therapy during or after the index procedure as per the protocol * Patient has uncontrolled hypercoagulation * Patient has a condition which may compromise or prevent the necessary imaging requirements * Patient has anatomic variants which would compromise circulation to the first branch off the target ar…